Special Issue "Cannabinoids in Cannabis: Chemistry, Pharmacology and Real World Evidence"
Deadline for manuscript submissions: closed (31 July 2020) | Viewed by 20138
Interests: drug discovery; enzyme inhibitors; cannabinoids; psychoactive molecules; multiple sclerosis; inflammatory disorders; mental health
Special Issues, Collections and Topics in MDPI journals
Cannabinoids, viz. endocannabinoids and phytocannabinoids, play an important role in a number of diseases spanning immunological, neurological and neuroimmunological conditions. These compounds interestingly act as ligands to a number of receptors and ion channels, such as CB1, CB2, GPR55, 5HT1A, and TRPV channels, among others. In recent years, there has been a renewed interest in almost all aspects of cannabinoids and the endocannabinoid system (ECS) due to the relaxation of regulations around the globe. This is permitting us to answer many questions that could not be answered until now, in the context of chemical modifications to cannabinoids, effects of cannabinoids on receptors, pharmacology and physiology, and associated clinical evidence. Chemical modifications to endocannabinoids and phytocannabinoids are important to probe the in vitro and in vivo pharmacology. Cannabinoids, in the form of various cannabis-derived products, are available in many countries, and research on these products and their effects on receptors—in animal models and in humans—are also very much relevant to health.
This Special Issue aims to bring together high-quality publications that appreciate and investigate the diversity of cannabinoid chemistry, the chemical complexity of cannabis, in vitro and in vivo studies involving cannabinoids and/or cannabis products, and real-world evidence on chemically defined cannabis products.
Prof. Lakshmi P. Kotra
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Endocannabinoid system
- Cannabinoid receptors
- Real world evidence
- Immune modulation
- In vitro studies
- In vivo studies
- Structure-activity relationship